Newsroom Navigation

Contact Info:
Office of Public Affairs
2000 Circle of Hope,
Salt Lake City, UT 84112

public.affairs@hci.utah.edu

801-587-7639

Recent News

Huntsman Cancer Institute Partners with National Cancer Institute on National Colorectal Cancer Outreach and Education Initiative
Press Releases, In The Media

Huntsman Cancer Institute Partners with National Cancer Institute on National Colorectal Cancer Outreach and Education Initiative

Huntsman Cancer Institute (HCI) at the University of Utah is partnering with the National Cancer Institute (NCI) to implement a nationwide colorectal cancer outreach and education initiative in support of increasing colorectal cancer screening rates in rural, frontier, and culturally diverse communities in Utah. The Screen to Save Initiative will launch in March at HCI and 48 other cancer centers around the nation, targeting average risk adults age 50 and older.

Read More

A Utah Scientist Powering the 'Cancer Moonshot'
In The Media

A Utah Scientist Powering the 'Cancer Moonshot'

It was one of those rare moments of bipartisanship: Then-Vice President Joe Biden visited the red state of Utah about a year ago and met with the enormously effective Republican Sen. Orrin Hatch and former Republican Gov. Jon M. Huntsman Jr. to discuss the C-word. Huntsman noted that “politics had been put aside” in support of Biden’s initiative to cure cancer — dubbed the “cancer moonshot.”

Read More

Actors Jeremy Renner and Elizabeth Olsen Visit Huntsman Cancer Institute Patients and Staff
News, In The Media

Actors Jeremy Renner and Elizabeth Olsen Visit Huntsman Cancer Institute Patients and Staff

Actors Jeremy Renner and Elizabeth Olsen spent two hours visiting patients at Huntsman Cancer Institute on Sunday, January 22. The “Avengers: Age of Ultron” and “Captain America: Civil War” co-stars were in town promoting their Sundance film “Wind River.” Before flying back to Los Angeles, they took time to stop by the hospital and talk with cancer patients and staff.

Read More

Huntsman Cancer Institute Scientists Identify Bone Degradation Process Within Metastatic Breast Cancer
Press Releases, In The Media

Huntsman Cancer Institute Scientists Identify Bone Degradation Process Within Metastatic Breast Cancer

Once breast cancer spreads through the body, it can degrade a patient’s healthy bones, causing numerous problems. Scientists at Huntsman Cancer Institute (HCI) at the University of Utah have identified a new way that bones get destroyed through cancer. And they’ve also learned how to block that destruction with a new drug. Initial tests with patients show promising results.

Read More

 Huntsman Cancer Institute Research Holds Promise for Personalized Lung Cancer Treatments
Press Releases, In The Media

Huntsman Cancer Institute Research Holds Promise for Personalized Lung Cancer Treatments

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified a targeted drug combination that worked well with one specific tumor type. The study was published today in Cancer Cell. The findings suggest small cell lung cancer should not be treated as a uniform disease

Read More

Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations
Press Releases, In The Media

Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations

Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).

Read More

hpv, cancer prevention

Using the Patient’s Immune System to Treat One of the Deadliest Cancers
In The Media, HCI News

Using the Patient’s Immune System to Treat One of the Deadliest Cancers

Pancreatic cancer is a deadly disease that presents unique challenges for researchers. Clinical trials at Huntsman Cancer Institute (HCI) are testing immunotherapy, medicines that stimulate the patient’s immune system, to boost the effects of standard chemotherapy drugs in treating pancreatic cancer.

Read More

Positive Side Effects: Your New Year’s Resolutions Could Reduce Your Cancer Risk
In The Media, HCI News

Positive Side Effects: Your New Year’s Resolutions Could Reduce Your Cancer Risk

For many of us, 2017’s New Year’s resolutions echo past resolutions we didn’t quite manage to keep. If your goals for 2017 include exercising more, eating better and cutting back on smoking or drinking, the experts at Huntsman Cancer Institute have some information that could help inspire success: these changes are also an integral part of protecting yourself against cancer.

Read More

Enough is Enough: Choosing the Right Treatment for Thyroid Cancer
In The Media, HCI News

Enough is Enough: Choosing the Right Treatment for Thyroid Cancer

When it comes to treating thyroid cancer, less can be more. The adage certainly proved true for Lisa Anderson. After the mother of one was diagnosed with papillary thyroid cancer, doctors at Huntsman Cancer Institute assessed her risk to decide which treatment would be most effective for her.

Read More

Holidays are Family Time: To Stay Healthy, Talk More than Turkey
In The Media, HCI News

Holidays are Family Time: To Stay Healthy, Talk More than Turkey

Sara learned she had a rare form of gastrointestinal cancer at the age of 37. She told her family and just a few weeks later, her brother had a check-up. His doctors found he had stage 4 colon cancer. Surprised and shaken by the coinciding diagnoses, Sara and her family turned to Samantha Greenberg, a genetic counselor at Huntsman Cancer Institute for answers.

Read More

Press Releases, In The Media

Huntsman Cancer Institute Leads International Colorectal Study

Huntsman Cancer Institute (HCI) at the University of Utah will head an international study to find out how lifestyle and other health factors impact colon and rectal cancer outcomes. HCI was awarded an $8.8 million grant from the National Institutes of Health to lead and expand an ongoing project in colon cancer research.

Read More

New progress against melanoma with trial therapies
In The Media, HCI News

New progress against melanoma with trial therapies

Melanoma is the most serious form of skin cancer. According to the American Cancer Society, when melanoma is caught early, there’s a 5-year survival rate of about 97%. Once the cancer spreads to other organs, the survival rate drops to 15–20%.

Read More

Targeted therapies offer hope for a hard-to-treat cancer
In The Media, HCI News

Targeted therapies offer hope for a hard-to-treat cancer

Diane Fouts thought she had a bad cold. It was the spring of 2015, and she had a cough that just wouldn’t go away. She went to see her doctor, who ordered a CT scan. The results were far more serious than a cold. Diane had lung cancer. She is not a smoker; in fact, she has never smoked.

Read More

The social aspect of cancer care
In The Media, HCI News

The social aspect of cancer care

Like any major illness, cancer affects more than the body. It wreaks havoc on the lives and emotions of patients and their families. Ask Judi Evans, who was diagnosed with stage 4 breast cancer and told she had just six months to live. “My daughter and I looked at each other, and we said ‘no, we're not accepting that.’ So we immediately came to Huntsman Cancer Institute.”

Read More

Huntsman Cancer Institute Commits to “Just Bag It”  To Eradicate Deadly Medical Error
In The Media, Press Releases

Huntsman Cancer Institute Commits to “Just Bag It” To Eradicate Deadly Medical Error

As part of its ongoing commitment to patient safety, Huntsman Cancer Institute (HCI) at the University of Utah is standing with a national campaign to end a dangerous chemotherapy error. Just Bag It: The NCCN Campaign for Safe Vincristine Handling, launched today by the National Comprehensive Cancer Network® (NCCN®), encourages health care providers to adopt a policy to always dilute and administer the medication vincristine in a mini IV-drip bag to prevent the improper administration of the drug.

Read More


Our media relations representatives are here to help reporters Monday-Friday, 7:30 am-5 pm.

Tonya Papanikolas
Public Affairs Manager
Phone: 801-587-7639
tonya.papanikolas@hci.utah.edu

Amie Parker
Public Relations Associate
Phone: 801-213-5755
amie.parker@hci.utah.edu

Jill Woods
Administrative Assistant
Phone: 801-585-5321
Fax: 801-585-0900
jill.woods@hci.utah.edu

After-hours calls: Reporters calling before or after business hours on an urgent matter can page the University of Utah Health on-call media relations representative at 801-581-7387 and press 1.